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ABSTRACT
Background and the purpose of the study: The quality of some of the human plasma derived 
drugs such as coagulation factor VIII and coagulation factor IX which can be used for the 
treatment of hemophilia A and B, depends on their activity which may be affected by filtration. 
In this study the quality of plasma with respect to coagulation factors FVII, FVIII, FIX, FV, 
FXI, Fibrinogen, antithrombin  III, anti-plasmin and antitrypsin activities obtained after plasma 
filtration with CPD (citrate-phosphate-dextrose) using integral filter was evaluated. 
Methods: Sixty units of plasma were individually separated from whole blood by centrifugation 
and immediately filtered by integral filter system. Specific plasma filtration was carried out 
between 4 and 20 hrs after blood donation. Before filtration, 60 units of non filtered fresh 
plasmas were kept as control. 
Coagulation  factors  were  determined  by  one-stage  clotting  assay  in  an  automated  system.   
Antithrombin III activity was determined by immunochrom assay in an automated system. 
Activity of anti-plasmin was determined by Berichrom α2 - antiplasmin  and antitrypsin activity 
was assayed with human neutrophil elastase. 
Results: The activity of coagulation factors FVIII, FIX, Fibrinogen, FV, and FXI,  were not 
affected by filtration, in all experiments. Filtration only caused negligible change in FVII activity.   
Antithrombin III, anti-plasmin and antitrypsin activities were not influenced by filtration. Non-
filtrated and filtrated plasma values were not significantly different (P> 0.05).    
Conclusions: Plasma filtration dose not result in a measurable impairment of coagulation factors 
and inhibitors. Although a little changes in FVII activity was observed after filtration, but these 
filtration-dependent changes apparently have no impact on the therapeutic quality of whole 
blood- filtered fresh plasma for transfusion.
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INTRODUCTION  
Plasma  filtration  is  one  of  the  methods  which 
has  been  applied  widely  for  leukocyte  depletion. 
The  benefits  of  leukocyte  depletion  had  been 
demonstrated in the reduction of alloimmunization 
(1), decrease in allergic and non- haemolytic febrile 
transfusion reactions (2)  and as a possible tool for 
prevention of transmission of prion infection such 
as  variant  Creutzfeld-Jakob  Disease  (vCJD)  by 
blood  components  (3).  The  main  disadvantages 
of  leukocyte  depletion  depend  to  some  technical 
problems, such as unclear effects of pre-filtration 
storage and the filtration process by itself (3-5).
The plasma protein of human blood, in particular, is 
of enormous value to the pharmaceutical industry in 
the production of therapeutics for the treatment of 
fibrinogenic, fibrinolytic and coagulation disorders 
and immunodeficiencies, such as haemophilia, von 
Willebrand’s disease and fibrinogen deficiency. The 
major therapeutic proteins are: albumin, with some 
degrees  of  purity;  immune  serum  globulin,  both 
normal and specific; anti-haemophilic factor such 
as  factor  VIII;  prothrombin  complex  comprising 
factors II, VII, IX, X; and fibrinogen or factor I (6). 
As it is known for plasmapheresis, an activation of 
the complement system by the filter material could 
be expected (7,8). In addition, a platelet-mediated 
clotting activation and an activation of neutrophils 
and monocytes on the filter material could not be 
excluded  (7-9).    The  present  study  evaluated  the 
quality of plasma in terms of activities of clotting 
factors  FVII,  FVIII,  FIX,  fibrinogen,  FV,  FXI, 
antithrombin  III,  anti-plasmin,  and  antitrypsin 
inhibitor  activity  after  plasma  filtration    by  an 
integral filter system.                                                
MATERIALS  AND  METHODS
Processing of blood donations 
Sixty units of whole blood were collected randomly 
114the means of continuous variables.  P. values <0.05 
were considered statistically significant.
RESULTS AND DISCUSSION
In this investigation a comparison of activities of 
FVIII, FIX, FV, FXI, Fibrinogen, antithrombin III, 
anti-plasmin, and antitrypsin in non- filtrated plasma 
with filtrated plasma from whole blood filtration by 
filtered bags, did not reveal significant differences. 
Filtration  caused  only  negligible  changes  in  FVII 
activity. 
Table 1 shows the activities of FVIII, FVII, FIX, FV, 
FXI, Fibrinogen, antithrombin III, anti-plasmin, and 
antitrypsin in non- filtrated plasma as control and   
filtrated plasma.  
Specific  plasma  filtration  is  a  practicable  way  to 
reduce  the  numbers  of  contaminating  leukocyte 
in FFP from non filtered (10). In this study, it was 
found that plasma filtration was efficient, yielding 
plasma with very few residual white blood cells (in 
all experiments, all WBC counts were <104 /l).
Results of this study by comparison of filtered and 
non- filtered  FFP showed that  storage of samples 
at – 40◦C up to 6 weeks until testing impaired neither 
the  activity  of  plasma  coagulation  factors  nor  of 
the inhibitors and in most coagulation factors were 
remained  intact.  Statistical  analysis  revealed  that 
non-filtrated  and  filtrated  plasma  values  are  not 
significantly different (P > 0.05).
In addition, the activity of coagulation factors FVIII, 
FIX, Fibrinogen, FV, and FXI, were not affected by 
filtration, and the inhibitors such as antithrombin III, 
anti-plasmin and antitrypsin were not influenced by 
filtration which is in close agreement with earlier 
from donors in Blood Transfusion Center of Tehran 
who met national criteria for blood donation. Donors 
were informed that their plasma would be used for 
experimental  investigations.  Fresh  plasma  was 
prepared from citrate-phosphate-dextrose (CPD) and 
it was filtered between 4 and 20 hrs after donation 
by an integral filter system with polyester fibers in 
polyvinyl chloride. 
Plasma filtration was performed immediately after 
plasma  separation.  Samples  (40  ml)  were  taken 
before and after filtration and spun down. The plasma 
was collected, aliquoted into 2 ml portions and stored 
frozen  at  –  40◦C up to 6 weeks until testing. Sixty 
units of non filtered fresh frozen plasmas were kept as 
control. All units of filtrated plasma had the quality to 
yield residual leukocyte count below 1x 106 per unit.  
Clotting assays  
The  following  parameters  were  tested  with 
commercially  available  test  kits  according  to  the 
manufacture’s instructions.  
Coagulation  factors  VII,  VIII,  IX,  FV,  FXI,  and 
Fibrinogen  were  determined  in  one-stage  clotting 
assay  (clot-based)  in  an  automated  system  (STA 
compact).  Antithrombin  III  was  determined  by 
immunochrom assay in an automated system (STA 
compact). Activity of anti-plasmin was determined 
by  Berichrom  α2-antiplasmin  (Dade  Behring, 
Schwalbach,  Germany)  and  antitrypsin  inhibitor 
activity was assayed with human neutrophil elastase 
(Serva, Heidelberg, Germany).
For all experiments, FVIII activity was measured 
immediately  after  the  first  thawing  of  the  2  ml 
aliquots at 37◦C. Student’s t- test was used to compare 
p-value Filtrated plasma*
n=60
Non -filtrated    plasma*
n=60
Parameter
(normal range)
0.59 225
130-417
230
145-396
Fibrinogen mg%   200-400
0.05 163
144-178
200
159-270
FVII
200-400%
0.05 84
205-250
96
170-279
FVIII
200-400%
0.1 91
88-110
101
70-129
FV
70-120%
0.270 70
81-88
72
66-100
FIX
50-150%
0.29 103
99-119
105
70-115
FXI
70-120%
Table 1.  Activities of non -filtrated plasma coagulation factor versus filtrate    plasma coagulation factors from whole blood filtration by 
integral filter system. 
* Figures are presented as median and average.
Non-filtrated and filtrated plasma values are not significantly different (P> 0.05).
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little effects on activities of the coagulation factors 
and did not increase factor of clotting and fibrinolysis. 
(7). In their experiments only a strong neutrophil 
activation was found which depended on the type of 
filter and whole blood storage conditions (7).  
Also in another report, plasma filtration appeared 
to have minimal effects on coagulation parameters 
(12),  where  a  significant  decrease  was  observed 
for factor VII in one sample and for factors IX and 
XI  in  two  samples.  Results  of  another  study  has 
shown that if whole blood filtration is performed 
after storage at room temperature, elastase release 
will  be  increased  (13).  Neutrophil  activation  has 
been reported to be involved in the generation of 
reactive  oxygen  species,  leading  to  a  diminished 
inhibitor capacity of antitrypsin (13). The neutrophil 
activation by filter material may be prevented by 
storage and subsequent filtration at 4◦C (13).   
In early studies, complement activation was observed 
with filters from different manufacture’s which all 
had the quality to yield residual leukocyte counts 
below 1x106 per unit (14). For some filters, post-
filtration values were reduced which were obviously 
due to the adsorptive properties of the filter material (14).
From the result of this study it may be concluded 
that plasma filtration has no effect on the quality 
of  plasma  in  terms  of  activity  of  coagulation 
factors  FVIII,  FIX,  FV,  FXI,  and  fibrinogen,  but 
decrease activity of FVII which may be due to the 
characterization of FVII.  FVII is the only factor 
which  can  be  found  active  by  itself  in  plasma. 
Also antithrombin III, anti-plasmin and antitrypsin 
activities were not influenced by filtration. 
However, these filtration-dependent changes apparently 
have no impact on the therapeutic quality of whole 
blood- filtered fresh plasma for transfusion.
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P-value Filtrated plasma*
 n=60         
Non -filtrated  plasma*
n=60
Parameter (normal range)
0.08 88
70-110
86
71-104
antithrombin III
80-120 %
0.09 90
86-119
88
90-113
anti-plasmin 
%80-120   
0.1 71
58-80
60
60-88
antitrypsin
57-125 %
Table 2.  Activities of non -filtrated plasma inhibitors versus filtrated   plasma inhibitors. 
* Figures are presented as median and average.
Non-filtrated and filtrated plasma values are not significantly different (P> 0.05).
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